Anti- Heartworm Polyclonal antibody

The French heartworm Angiostrougylus vasorum is a parasitic nematode that lives in the pulmonary vessels and the heart of canids. Transmission occurs through ingestion of infected intermediate hosts, such as snails and slugs. There are increasing reports of autochthonous infections in our neighbouring countries. Clinical signs usually relate to the respiratory system, coagulopathy and the neurologic system. Anorexia, gastrointestinal dysfunction and weight loss are also frequently observed. Diagnosis is not straightforward, but abnormalities detected by thoracic radiography, echocardiography, magnetic resonance imaging (MRI) or computed tomography (CT) scan can be helpful. Eosinophilia, regenerative anemia and thrombocytopenia with or without abnormalities in the coagulation profile can occur. Definitive diagnosis is made by demonstrating the parasite in the cerebrospinal fluid, in faeces (Baermann technique) and/or in bronchoalveolar lavage fluid. Treatment consists of anthelmintic drugs and supportive care if necessary.

Throughout the end of March to beginning of May 2006, 212 owned cats and 608 owned dogs from a heavy endemic area for canine heartworm (HW) disease in northern Italy have been examined to assess HW infection prevalence. Both cats and dogs were clinically examined and blood samples were taken from each animal to be examined for HW antibody (Ab). Ab-positive cats were further examined for circulating microfilariae, HW antigens (Ag) and by echocardiography (ECHO) to assess the presence of adult worms. Dogs were clinically examined and blood samples taken from each animal were examined for circulating microtilariae and for HW Ag. Ten cats (4.7%) were found Ab positive. Of these, 6 cats were Ag positive (2.6%) and in 4 (1.8%) the worms were visualized by ECHO. HW prevalence in dogs was 36% (221/608). One hundred and seventy-six (29%) were both microfilaraemic and Ag positive, 40 (7%) had occult infections (no circulating microfilariae) and 7 (1%) were, microfilaraemic but Ag negative. Upon owners' consent, 132 cats (including cats Ab and/or Ag and ECHO positive) were prophylactically treated against HW disease with an imidacloprid/moxidectin spot-on combination (10% imidacloprid/1% moxidectin) monthly administered for 6 months. Cats were re-examined for HW infection in November, 1 month after the last drug administration, and in May-June 2007, 7-8 months after the last treatment. All 122 cats found HW negative before treatment, were found negative at the two examinations at the end of study. The 4 cats Ab positive, 2 cats Ab and Ag positive and I Ab, Ag and ECHO positive at the beginning of treatment were found negative. Throughout the treatment, transitory hypersalivation and generic signs of annoyance were reported by owners in 6 cats (4.5%). All signs regressed spontaneously. (c) 2008 Elsevier B.V. All rights reserved.